WO2013016701A1 - Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield - Google Patents
Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield Download PDFInfo
- Publication number
- WO2013016701A1 WO2013016701A1 PCT/US2012/048713 US2012048713W WO2013016701A1 WO 2013016701 A1 WO2013016701 A1 WO 2013016701A1 US 2012048713 W US2012048713 W US 2012048713W WO 2013016701 A1 WO2013016701 A1 WO 2013016701A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- shield
- shielding device
- distal portion
- treatment site
- tubes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1094—Shielding, protecting against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1014—Intracavitary radiation therapy
- A61N5/1016—Gynaecological radiation therapy
Definitions
- the present invention relates generally to a shielding device for use during radiation treatment, an assembly
- a patient's rectum and/or bladder may be subjected to
- Example embodiments of the present invention prevent undesirable exposure to radiation of healthy organs, for example, the rectum and/or bladder when treating a patient's cervix, by physically lifting and/or pushing the rectum and/or bladder away from the treatment site as far as anatomically possible using a shielding device.
- the bladder may be lifted up from its sagging position and pushed anterior and away from the cervix.
- the shielding device may include an exchangeable and/or moveable shield, for example, made of tungsten, to further reduce exposure to radiation of healthy organs.
- the shield may be removed, exchanged, and/or moved as required in order to facilitate imaging, treatment planning, and/or actual treatment .
- a shielding device may include two elongated, parallel tubes joined at a distal portion, and a shield at least one of removably and slidably situated at the distal portion.
- the distal portion may be angled up to about 10 degrees relative to a plane defined by the tubes, and may include at least one of a U-shaped and a circular portion.
- the tubes may include markings configured to indicate a longitudinal position, and may be made of medical grade titanium .
- the shield may be made of tungsten/or and brass, and may be between about 2mm to about 5mm thick.
- the shield may be configured to extend at least a length of the distal portion along a longitudinal axis of the tubes.
- the shield may include grooves for attachment to the tubes.
- the distal portion may include a separate shield retainer attached to distal ends of the tubes.
- the shield retainer may include a retaining lip and a key slot configured to retain the shield
- the shield may include a retaining ring and a key portion configured to be received by the retaining lip and the key slot, respectively.
- the shielding device may be configured to be attached to an applicator via a rotary unit and an assembly block.
- the shielding device may be movable within the rotary unit and the assembly block at least one of longitudinally along a
- the shielding device may be configured to at least one of move and shield one of a bladder and a rectum during treatment of a patient's cervix .
- an assembly may include an applicator configured for a treatment site, an assembly block attached to the applicator, at least one rotary unit configured to be
- each respective shielding device including two elongated, parallel tubes joined at a distal portion, and a shield at least one of removably and slidably situated at the distal portion, in which the tubes of a respective
- shielding device are configured to be movably received in a respective rotary unit.
- the assembly except for the shield, may be made of medical grade titanium.
- the assembly block may be attached to the applicator via an applicator lock screw, and may include a circular hole, an elongated hole, and/or a U-shaped hole for receiving the applicator.
- the rotary unit may be rotatably retained in the assembly block via a capture screw.
- the tubes may be secured in the rotary unit via shield depth lock screws.
- the rotary unit may include a pivot pin, and the assembly block may include at least one angle adjustment screw configured to interact with the pivot pin, the pivot pin and the angle adjustment screw configured to set a rotational position of the rotary unit when received in the assembly block.
- the pivot pin may be triangular and/or rectangular.
- adjustment screw may include an angle location lock nut configured to reproducibly set the rotational position.
- the shielding device may be configured to move and/or shield a bladder and/or a rectum during treatment of a
- a method of using a shielding device with an applicator may include inserting the distal portion of the shielding device to a treatment site, and adjusting a position of the distal portion relative to a distal end of the
- the adjusting may include setting a longitudinal depth of insertion of the distal portion, and setting a rotational position of the distal portion relative to the distal end of the applicator.
- the method may further include after the adjusting, removing the distal portion of the shielding device from the treatment site, and reproducibly reinserting the distal portion to a previously adjusted position.
- the method may further include moving, removing, and/or exchanging the shield.
- the method may further include sliding the shield relative to the tubes while the distal portion of the shielding device is inserted to the treatment site.
- elongated, parallel tubes joined at a distal portion, and a shield at least one of removably and slidably situated at the distal portion may include inserting the distal portion of the shielding device to a treatment site of a patient, the shield being made of plastic; imaging the treatment site;
- the method may further include after the inserting of the distal portion, adjusting a position of the distal portion relative to a distal end of the applicator.
- the adjusting may include setting a longitudinal depth of insertion of the distal portion and/or setting a rotational position of the distal portion relative to the distal end of the applicator.
- the method may further include after the adjusting, and before the removing of the distal portion, returning the distal portion to an unadjusted position.
- the method may further include after the returning to the unadjusted position, and after the removing and the inserting of the distal portion, reproducibly adjusting the distal portion to a previously adjusted position.
- the method may further include at least one of moving and removing the shield.
- the method may further include sliding the shield
- shielding device is inserted to the treatment site.
- the imaging may include at least one of fluoroscopy, computed tomography scanning, and magnetic resonance imaging.
- Figure 1 shows a perspective view of a first exemplary embodiment of an assembly including a shielding device
- Figures 2A to 2C show perspective, top and side views of a first exemplary embodiment of a portion of a shielding device according to the present invention.
- Figures 3A to 3F show top, side, bottom, proximal end, top perspective and bottom perspective views of a first exemplary embodiment of a shield according to the present invention .
- Figures 4A and 4B show perspective views of different positions of a first exemplary embodiment of the shielding device according to the present invention.
- Figure 5 shows a close-up, perspective view of a first exemplary embodiment of a rotary unit according to the present invention .
- Figures 6A to 6C show proximal end, top and side views of a first exemplary embodiment of a portion of a rotary unit according to the present invention.
- Figures 7A to 7C show top, side and distal end views of a first exemplary embodiment of a pivot pin of a rotary unit according to the present invention.
- Figures 8A and 8B show side and end views of a first exemplary embodiment of a shield depth lock screw of a rotary unit according to the present invention.
- Figures 9A to 9D show top, side, proximal end and top perspective views of a first exemplary embodiment of the shielding device, rotary unit and assembly block according to the present invention.
- Figures 10A to 10D show top, proximal end, side and distal end views of a first exemplary embodiment of a portion of an assembly block according to the present invention.
- Figure 11 shows a close-up, perspective view of a first exemplary embodiment of a rotary unit and assembly block according to the present invention.
- Figure 12 shows a perspective view of a second exemplary embodiment of a partially assembled assembly including a shielding device according to the present invention.
- Figure 13 shows a perspective view of a second exemplary embodiment of a fully assembled assembly including a shielding device according to the present invention.
- Figures 14A to 14C show top, side and proximal end views of the second exemplary embodiment of a fully assembled assembly including a shielding device according to the present invention .
- Figures 15A to 15E show perspective, proximal end, top, cross-sectional and side views of a second exemplary
- Figures 16A to 16D show perspective, proximal end, bottom and side views of a second exemplary embodiment of a shield of a shielding device according to the present invention.
- Figure 17 schematically shows a method of using an exemplary embodiment of a shielding device according to the present invention.
- Figure 18 shows a perspective view of a third exemplary embodiment of a fully assembled assembly including a bladder shielding device and a rectal retractor according to the present invention.
- Figures 19A to 19D show perspective, top, side and proximal end views of a third exemplary embodiment of a rectal retractor according to the present invention.
- Figures 20A to 20E show perspective, top, side, bottom and proximal end views of a third exemplary embodiment of a shield of a rectal retractor according to the present
- Figure 1 shows a perspective view of a first exemplary embodiment of an assembly 1 including a shielding device 20 according to the present invention.
- the assembly 1 may be designed for use with high dose rate ring-tandem applicators 10, high dose rate split ring applicators, or other suitable applicators. Regardless of the specific type of applicator used with the assembly 1, the shielding device 20 provides displacement and/or shielding of healthy organs near the treatment site.
- the assembly includes an applicator 10, a shielding device 20, a rotary unit 30, and an assembly block 40.
- the applicator 10 may be a ring-tandem applicator including a ring 11 and a tandem 12 joined to each other at a block 13.
- the applicator 10 may include a rectal retractor 14, also joined at the block 13.
- a particular embodiment of an applicator 10 is shown in the Figures, it is understood that any suitable applicator may be used with the shielding device 20.
- Figures 2A to 2C show perspective, top and side views of a first exemplary embodiment of a portion of a shielding device 20.
- the shielding device 20 includes two tubes 21 that extend longitudinally substantially parallel with each other and with the applicator 10. At a distal end of the tubes 21, the shielding device 20 includes a substantially circular and/or U-shaped distal portion 22 that joins the two tubes 21. Alternatively, the distal portion 22 may include other shapes, e.g., oval, polygonal, and others.
- the tubes 21 and distal portion 22 may extend approximately 9- 1/2 inches, and the diameter of the tubes may be approximately 1/8 inch.
- the proximal ends of the tubes 21 may include spherical buttons (not shown) for safety and/or aesthetics.
- the tubes 21 and distal portion 22 may be made of medical grade titanium, for example. Further, as shown in Figure 2C, the distal portion 22 may be angled relative to a plane
- the two tubes 21 defined by the two tubes 21 by up to 10 degrees, preferably about 5 degrees.
- Figures 3A to 3F show top, side, bottom, proximal end, top perspective and bottom perspective views of a first
- FIG. 4A and 4B show perspective views of different positions of a first exemplary embodiment of the shielding device 20.
- the shield 23 includes a proximal section 24 and a distal section 25.
- the proximal section 24 and at least a part of the distal section 25 include grooves 26 that allow the shield 23 to be snapped into position between the two tubes 21 and to be slid longitudinally between the two tubes 21, as shown in Figures 4A and 4B.
- the distal section 25 is shaped to
- the shield 23 may be configured to extend at least a length of the distal section 25 along a
- the shield 23 extends beyond the distal section 25 into the proximal section 24 such that the shield 23 may be reliably secured between the two tubes 21 by grooves 26.
- the shield 23 may be made of tungsten and/or brass, for example. Further, the shield 23 may be between about 2mm thick to about 5mm thick, preferably about 3mm thick.
- a position of the shielding device 20 may be more easily confirmed by imaging, e.g., fluoroscopy, CT scanning, and/or MRI .
- the shield 23 may be slid distally, as shown in Figure 4B, prior to beginning treatment.
- the shield 23 may be removed, exchanged, and/or positioned as necessary during all phases of imaging, treatment planning, and actual treatment .
- Figure 5 shows a close-up, perspective view of a first exemplary embodiment of a rotary unit 30.
- the rotary unit 30 includes shielding device receiving portions 31 having receiving holes 32 and shield depth lock screws 33.
- the shielding device receiving portions 31 are joined by a bearing portion 34 having a pivot pin 35.
- the two tubes 21 of the shielding device 20 are received in the holes 32.
- the tubes 21 may be adjusted longitudinally to a desired insertion depth, and the tubes 21 may be locked in position by rotating the shield depth lock screws 33.
- the rotary unit 30 may be made of medical grade titanium, for example.
- Figures 6A to 6C show proximal end, top and side views of a first exemplary embodiment of a portion of a rotary unit 30.
- Figures 7A to 7C show top, side and distal end views of a first exemplary embodiment of a pivot pin 35 of a rotary unit 30.
- Figures 8A and 8B show side and end views of a first exemplary embodiment of a shield depth lock screw 33 of a rotary unit 30.
- the rotary unit 30 includes shielding device receiving portions 31 having receiving holes 32.
- the shielding device receiving portions 31 are joined by a bearing portion 34.
- the bearing portion 34 includes a pivot pin receiving hole 36, as shown in Figures 6A and 6B, in which a pivot pin 35 may be inserted, preferably permanently.
- the pivot pin 35 as shown in 7A to 7C, includes an inserting pin 37 that is received by pivot pin receiving hole 36.
- the pivot pin 35 may be formed integrally with bearing portion 34 of rotary unit 30.
- the pivot pin 35 may be triangular in order to provide a range of angles of the shielding device 20 relative to the applicator 10.
- the pivot pin 35 may be possible, such as for example, rectangular, circular, and/or polygonal, as long as a sufficient range of angles of the shielding device 20 relative to the applicator 10 is possible.
- the shield depth lock screws 33 as shown in Figures 8A and 8B, may be held captive in the rotary unit 30, such that they cannot be completely removed from the rotary unit 30. Further, the screws 33 may have knurled surfaces to facilitate manual operation of the screws 33.
- Figures 9A to 9D show top, side, proximal end and top perspective views of a first exemplary embodiment of the shielding device 20, rotary unit 30, and assembly block 40.
- Figures 10A to 10D show top, proximal end, side and distal end views of a first exemplary embodiment of a portion of an assembly block 40.
- the assembly block 40 is configured to receive the
- the assembly block 40 includes a circular hole 41 and a U-shaped hole 42 configured to received the applicator 10. Further, the assembly block 40 includes an applicator lock screw
- receiving hole 44 that receives an applicator lock screw, e.g., similar to shield depth lock screw 33, that locks the
- the assembly block 40 may include additional holes 43 for weight reduction.
- the assembly block 40 includes a rotary unit receiving portion 46 and an angle adjustment screw hole 47 that receives an angle adjustment screw configured to interact with the rotary unit 30 to set an angle of the shielding device 20 relative to the applicator 10.
- the assembly block 40 may be made of medical grade titanium, for example.
- Figure 11 shows a close-up, perspective view of a first exemplary embodiment of a rotary unit 30 and assembly block 40.
- the applicator 10, including ring 11, tandem 12 and optional rectal retractor 14 held together by block 13, is received in holes 41, 42 of assembly block 40 and locked in place by applicator lock screw 45.
- tubes 21 of shielding device 20 are received in rotary unit 30 and locked in place by shield depth lock screws 33.
- the bearing portion 34 of rotary unit 30 is received in rotary unit
- Angle adjustment screw 48 is adjusted to interact with pivot pin 35 of rotary unit 30 to set an angle of shielding device 20 relative to applicator 10.
- the shielding device 20 is movable within the rotary unit 30 longitudinally along a longitudinal axis of the two tubes 21. Additionally, the shielding device 20 and rotary unit 30 are movable within the assembly block 40
- the assembly 1 including the shielding device 20 is configured to move and/or shield a bladder and/or a rectum during treatment of a patient's cervix.
- the shielding device 20 allows for following the principle of radiation protection: time, distance, and shielding. That is, the duration of radiation treatment can be optimally set for the treatment site without compromising the prescription dose, while protecting healthy organs via increased distance and/or shielding from radiation exposure.
- Figure 12 shows a perspective view of a second exemplary embodiment of a partially assembled assembly 100 including a shielding device 120.
- Figure 13 shows a perspective view of a second exemplary embodiment of a fully assembled assembly 100 including a shielding device 120.
- Figures 14A to 14C show top, side and proximal end views of the second exemplary embodiment of a fully assembled assembly 100 including a shielding device 120.
- the assembly 100 includes an applicator 110, two shielding devices 120, two rotary units 130 and an assembly block 140.
- the applicator 110 includes a ring 111 and tandem 112 joined at a block 113.
- the assembly 100 may be designed for use with high dose rate ring-tandem applicators 110, high dose rate split ring applicators, or other suitable applicators. Regardless of the specific type of applicator used with the assembly 100, the shielding device 120 provides displacement and/or shielding of healthy organs near the treatment site.
- Figures 15A to 15E show perspective, proximal end, top, cross-sectional and side views of a second exemplary
- FIGS. 16A to 16D show perspective, proximal end, bottom and side views of a second exemplary embodiment of a shield 123 of a shielding device 120.
- Each shielding device 120 includes two tubes 121, a shield retainer 122 at a distal end of the tubes 121, and a shield 123.
- the shield retainer 122 is substantially circular and/or U-shaped and joins distal ends of the two tubes 121.
- the shield retainer 122 may include other shapes, e.g., oval, polygonal, and others.
- the tubes 121 and shield retainer 122 may extend approximately 9-1/2 inches, and the diameter of the tubes may be approximately 1/8 inch.
- the proximal ends of the tubes 121 may include spherical buttons (not shown) for safety and/or aesthetics.
- the tubes 121 and shield retainer 122 may be made of medical grade titanium, for example. Further, the shield retainer 122 may be angled relative to a plane defined by the two tubes 121 by up to 10 degrees, preferably about 5 degrees.
- the shield 123 may be shaped to correspond to the shield retainer 122 of the shielding device 120.
- the shield 123 may be made of tungsten and/or brass, for example. Further, the shield 123 may be between about 2mm thick to about 5mm thick, preferably about 3mm thick.
- the shield retainer 122 may include a retaining lip 124 and a key slot 125 configured to retain the shield 123.
- the shield 123 may include a retaining ring 126 and a key portion 127 configured to be received by the shield 123
- the shield 123 When the shield 123 is to be attached to the shield retainer 122, the shield 123 may be rotated and attached to shield retainer 122 such that the retaining ring 126 is
- the shield 123 may be rotated to engage retaining lip 124 with retaining ring 126. Further, when the shield 123 is fully rotated to the assembled position as shown in Figure 13, for example, the key portion 127 of shield 123 may be received within key slot 125 of shield retainer 122.
- the shield 123 may be positively secured within shield retainer 123 to prevent inadvertent disassembly of the shield 123 from the shielding device 120, especially during treatment.
- the shield 123 may be removed by reversing the order of the steps described above.
- the shield 123 may be removed,
- each rotary unit 130 includes shielding device receiving portions 131 having
- the shielding device receiving portions 131 are joined by a
- each shielding device 120 is received and longitudinally situated within receiving holes 132 of a respective rotary unit 130.
- the tubes 121 may be adjusted longitudinally to a desired insertion depth, and the tubes 121 may be locked in position by rotating the shield depth lock screws 133.
- the tubes 121 may further include markings and/or grooves 128 that indicate a depth of insertion of the shielding device 120.
- the markings 128 may be placed every 5mm and/or lcm, or any other length, along the tubes 121.
- the markings 128 may be the same or different from each other. By the use of such markings 128, a longitudinal position of the shielding device 120 may be set such that the shielding device 120 may be reproducibly inserted to a desired depth.
- the rotary unit 130 may be made of medical grade titanium, for example .
- the pivot pin 135 may be triangular in order to provide a range of angles of the shielding device 120 relative to the applicator 110.
- other shapes of the pivot pin 135 may be possible, such as for example, rectangular,
- the shield depth lock screws 133 may be held captive in the rotary unit 130, such that they cannot be completely removed from the rotary unit 130. Further, the screws 133 may have knurled surfaces to facilitate manual operation of the screws 133.
- the assembly block 140 receives ring 111 and tandem 112 of applicator 110 in holes 141, 142 of assembly block 140, and the applicator lock screw 145 secures the applicator 110 in place.
- the assembly block 140 may be made of medical grade titanium, for example.
- each rotary unit 130 is received in a rotary unit receiving portion 146 of assembly block 140. After insertion, the bearing portion 134 may be retained, while maintaining rotational freedom, by a capture screw 150.
- the angle of the rotary unit 130 may be adjusted by inserting, into angle adjustment screw hole 147, an angle adjustment screw 148 that interacts with the pivot pin 135 of the rotary unit 130.
- an angle location lock nut 149 may be provided on angle adjustment screw 148 to reproducibly set a rotational position of rotary unit 130. That is, when the angle adjustment screw 148 is inserted to a desired depth, the angle location lock nut 149 may be turned to abut against assembly block 140, thereby setting an
- the shielding device 120 is movable within the rotary unit 130 and can be set to a reproducible longitudinal position along a longitudinal axis of the two tubes 121. Additionally, the shielding device 120 and rotary unit 130 are movable within the assembly block 140 and can be set to a reproducible rotational position with respect to a distal end of the applicator 110.
- the assembly 100 including the shielding device 120 is configured to move and/or shield a bladder and/or a rectum during treatment of a patient's cervix. Further, as shown in Figures 12 to 14C, by the provision of a shielding device 120 on opposite sides of the applicator 110, one shielding device may shield the bladder and the other shielding device may simultaneously shield the rectum during radiation treatment of a patient's cervix.
- the shielding device 120 allows for following the principle of radiation protection: time, distance, and shielding. That is, the duration of radiation treatment can be optimally set for the treatment site without compromising the prescription dose, while protecting healthy organs via increased distance and shielding from radiation exposure .
- Figure 17 schematically shows a method 200 of using an exemplary embodiment of a shielding device.
- a distal end of an applicator may be
- a distal portion of the shielding device is inserted to the treatment site, and at step 206, a position of the distal portion is adjusted relative to a distal end of the applicator.
- the adjustment may include longitudinal and/or rotational adjustment of the shielding device relative to the applicator. That is, a longitudinal depth of insertion of the shielding device may be adjusted and/or reproducibly set, for example, by moving the tubes 21, 121 based on markings 128 and thereafter locking the tubes by shield depth lock screws 33, 133; a rotational position of the shielding device may be adjusted and/or reproducibly set, for example, by rotating the shielding device and rotary unit using pivot pin 35, 135, angle
- the distal portion of the shielding device may be removed from the treatment site at step 208.
- the shield may be moved, removed, and/or exchanged at step 210.
- the distal portion of the shielding device may be reproducibly reinserted to the
- previously adjusted position i.e., the previously adjusted and/or set longitudinal and rotational positions.
- the shield may be slid relative to the two tubes while the distal portion of the shielding device remains inserted to the treatment site.
- radiation treatment may be performed.
- imaging e.g., fluoroscopy, CT (computed tomography) scanning and/or MRI (magnetic resonance imaging)
- CT computed tomography
- MRI magnetic resonance imaging
- the shielding device may initially have no shield or a shield of different material, e.g., plastic such as delrin, that does not interfere with imaging.
- the shield may be added or, in the case of a plastic shield, exchanged, prior to beginning radiation treatment.
- the shielding device may be used without a shield during radiation treatment, such that the shielding device then serves primarily to move the bladder and/or rectum during treatment.
- the method may comprise the
- a position of the distal portion may be adjusted 206.
- the position of the distal portion may be adjusted before, during and/or after imaging of the treatment site.
- the adjusting of the position of the distal portion 206 may include setting a longitudinal depth of insertion of the distal portion and/or setting a rotational position of the distal portion relative to the distal end of the applicator, as more fully described above.
- the distal portion may be returned to its unadjusted position before removing the distal portion 208 from the treatment site.
- the distal portion may be returned to its unadjusted position by changing the rotational position and/or the longitudinal position of the distal portion. It may be possible and/or preferable to return only the rotational position of the distal portion to the unadjusted position before removing the distal portion, and leaving the longitudinal position of the distal portion in its adjusted state.
- the distal portion may be removed 208 from the treatment site. After removing the distal portion 208, and exchanging the shield 210 made of plastic with a shield made of tungsten, the distal portion may be inserted 212 into the treatment site again. Once inserted, a position of the distal portion may be reproducibly adjusted to a previously adjusted position. Thus, the adjusting may only need to be completed one time for a particular treatment of a patient. Thereafter, the distal portion of the shielding device can be removed and inserted multiple times while still allowing the position of the distal portion to be reproducibly adjusted to the
- the method may further include the step of moving and/or removing 210, 214 the shield.
- the moving may include sliding the shield 214 relative to the tubes while the distal portion of the shielding device is inserted to the treatment site.
- the shield may be moved and/or removed 210, 214 when the distal portion is removed from the patient. Further, the distal portion may be inserted to the treatment site without any shield, such that the shielding device then serves
- Figure 18 shows a perspective view of a third exemplary embodiment of a fully assembled assembly 300 including a bladder shielding device 320 and a rectal retractor 360.
- the assembly 300 includes an applicator 310, a bladder shielding device 320, a rectal retractor 360, two rotary units 330, one for each of the bladder shielding device 320 and the rectal retractor 360, and an assembly block 340.
- the applicator 310 includes a ring and tandem joined at a block, similar to that described with reference to the first and second exemplary embodiments.
- the assembly 300 may be designed for use with high dose rate ring- tandem applicators 310, high dose rate split ring applicators, or other suitable applicators. Regardless of the specific type of applicator used with the assembly 300, the bladder shielding device 320 and the rectal retractor 360 provide displacement and/or shielding of healthy organs, i.e., bladder and rectum, respectively, near the treatment site.
- the bladder shielding device 320 is similar to that described with reference to the first exemplary embodiment.
- the bladder shielding device 320 includes a substantially circular distal portion that joins the two tubes and a correspondingly shaped shield, and the distal portion is angled relative to a plane defined by the two tubes by about 5 degrees.
- the rotary units 330 are similar to those described with reference to the first and second exemplary embodiments, and the assembly block 340 is similar to that described with reference to the second
- Figures 19A to 19D show perspective, top, side and
- FIG. 20A to 20E show perspective, top, side, bottom and proximal end views of a third exemplary embodiment of a shield 363 of a rectal retractor 360.
- the rectal retractor 360 includes two tubes 361 that extend longitudinally substantially parallel with each other and with the applicator 310. At a distal end of the tubes 361, the rectal retractor 360 includes a substantially U-shaped distal portion 362 that joins the two tubes 361. Accordingly, the rectal retractor 360 may resemble a "tuning fork," in which the distal portion 362 does not have an enlarged
- the distal portion 362 does not substantially extend laterally beyond the substantially parallel, longitudinally extending tubes 361.
- the tubes 361 and distal portion 362 may extend approximately 9-1/2 inches, and the diameter of the tubes may be
- the proximal ends of the tubes 361 may include spherical buttons (not shown) for safety and/or aesthetics.
- the tubes 361 and distal portion 362 may be made of medical grade titanium, for example.
- the shield 363 includes a proximal section 364 and a distal section 365.
- the proximal section 364 and at least a part of the distal section 365 include grooves 366 that allow the shield 363 to be snapped into position between the two tubes 361 and to be slid longitudinally between the two tubes 361.
- the distal section 365 is shaped to correspond to the distal portion 362 of the rectal retractor 360, which may be substantially U-shaped and resemble a "tuning fork, " for example.
- the shield 363 may be configured to extend at least a length of the distal section 365 along a longitudinal axis of the two tubes 361.
- the shield 363 extends beyond the distal section 365 into the proximal section 364 such that the shield 363 may be reliably secured between the two tubes 361 by grooves 366.
- the shield 363 may be made of tungsten and/or brass, for example. Further, the shield 363 may be between about 2mm thick to about 5mm thick, preferably about 3mm thick.
- a position of the tubes 361 of the rectal retractor 360 may be more easily confirmed by imaging, e.g., fluoroscopy, CT scanning, and/or MRI .
- the shield 363 may be slid distally, prior to beginning treatment.
- the shield 363 may be removed, exchanged, and/or positioned as necessary during all phases of imaging, treatment planning, and actual treatment.
- a plastic shield 363 may be inserted into the rectal retractor 360 in place of a tungsten shield 363, similar to that described with reference to the shielding device in the method of Figure 17.
- a rotary unit 330 and assembly block 340 may receive the rectal retractor 360 in a manner similar to that described with reference to the shielding device, rotary unit and assembly block of the first and second exemplary embodiments.
- the rectal retractor 360 may be longitudinally and/or rotationally adjusted, and/or locked in position, within rotary unit 330 and assembly block 340.
- the two tubes 361 of the rectal retractor 360 may include markings and/or grooves that indicate a depth of insertion of the rectal retractor 360, such that a longitudinal position of the rectal retractor 360 may be set, and the rectal retractor 360 may be reproducibly inserted to a desired depth.
- the rectal retractor 360 is movable within the rotary unit 330 and can be set to a reproducible longitudinal position along a longitudinal axis of the two tubes 361. Additionally, the rectal retractor 360 and rotary unit 330 are movable within the assembly block 340 and can be set to a reproducible rotational position with respect to a distal end of the applicator 310.
- the assembly 300 including the bladder shielding device 320 and rectal retractor 360 is configured to move and/or shield a bladder and a rectum, respectively, during treatment of a patient's cervix.
- the shielding device 320 may move and/or shield the bladder and the rectal retractor 360 may simultaneously move and/or shield the rectum during radiation treatment of a patient's cervix.
- the shielding device 320 and rectal retractor 360 allow for following the principle of radiation protection: time, distance, and shielding. That is, the duration of radiation treatment can be optimally set for the treatment site without compromising the prescription dose, while protecting healthy organs via increased distance and shielding from radiation exposure.
- each of the shielding devices and/or rectal retractor may be manipulated individually and/or independently of each other.
- each shielding device and/or rectal retractor for either the bladder or the rectum may be used only one-at-a-time . That is, only a shielding device for the bladder may be used, or only a shielding device or rectal retractor for the rectum may be used.
- Ir-192 may be configured to perform the radiation treatment.
- Ir-192 may be configured to perform the radiation treatment.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112014001790A BR112014001790A2 (en) | 2011-07-27 | 2012-07-27 | method of using at least one shielding device with an applicator |
EP20120816877 EP2736599A4 (en) | 2011-07-27 | 2012-07-27 | Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield |
CA2843027A CA2843027A1 (en) | 2011-07-27 | 2012-07-27 | Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield |
CN201280036293.8A CN103702718A (en) | 2011-07-27 | 2012-07-27 | Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield |
RU2014108022/14A RU2014108022A (en) | 2011-07-27 | 2012-07-27 | BLADDER HOLDER AND / OR DIRECT GUT WITH REMOVABLE AND / OR MOBILE TUNGSTEN SCREEN |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161512387P | 2011-07-27 | 2011-07-27 | |
US61/512,387 | 2011-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013016701A1 true WO2013016701A1 (en) | 2013-01-31 |
Family
ID=47601575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/048713 WO2013016701A1 (en) | 2011-07-27 | 2012-07-27 | Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2736599A4 (en) |
CN (1) | CN103702718A (en) |
BR (1) | BR112014001790A2 (en) |
CA (1) | CA2843027A1 (en) |
RU (1) | RU2014108022A (en) |
WO (1) | WO2013016701A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3807386A (en) * | 1971-04-27 | 1974-04-30 | Commissariat Energie Atomique | Radioactive source applicator for utero-vaginal plesiocurietherapy according to the method of non-radioactive preparation |
US5012357A (en) * | 1989-03-20 | 1991-04-30 | University Of Michigan | CT compatible intracavity radiation applicator with afterloading shielding |
US20020120175A1 (en) * | 2000-11-22 | 2002-08-29 | Tim Luth | Method and apparatus for positioning and discharging radiation sources in biological tissue by way of hollow needles |
US20070027352A1 (en) * | 2004-07-20 | 2007-02-01 | Board Of Regents, The University Of Texas System | Adaptive intracavitary brachytherapy applicator |
US20100036190A1 (en) * | 2008-06-24 | 2010-02-11 | Murphy Brent D | Internal radiation shield for brachytherapy treatment |
US20100237259A1 (en) * | 2009-03-23 | 2010-09-23 | Chao Wang | Method and device for image guided dynamic radiation treatment of prostate cancer and other pelvic lesions |
-
2012
- 2012-07-27 CN CN201280036293.8A patent/CN103702718A/en active Pending
- 2012-07-27 BR BR112014001790A patent/BR112014001790A2/en not_active IP Right Cessation
- 2012-07-27 RU RU2014108022/14A patent/RU2014108022A/en not_active Application Discontinuation
- 2012-07-27 EP EP20120816877 patent/EP2736599A4/en not_active Withdrawn
- 2012-07-27 WO PCT/US2012/048713 patent/WO2013016701A1/en active Application Filing
- 2012-07-27 CA CA2843027A patent/CA2843027A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3807386A (en) * | 1971-04-27 | 1974-04-30 | Commissariat Energie Atomique | Radioactive source applicator for utero-vaginal plesiocurietherapy according to the method of non-radioactive preparation |
US5012357A (en) * | 1989-03-20 | 1991-04-30 | University Of Michigan | CT compatible intracavity radiation applicator with afterloading shielding |
US20020120175A1 (en) * | 2000-11-22 | 2002-08-29 | Tim Luth | Method and apparatus for positioning and discharging radiation sources in biological tissue by way of hollow needles |
US20070027352A1 (en) * | 2004-07-20 | 2007-02-01 | Board Of Regents, The University Of Texas System | Adaptive intracavitary brachytherapy applicator |
US20100036190A1 (en) * | 2008-06-24 | 2010-02-11 | Murphy Brent D | Internal radiation shield for brachytherapy treatment |
US20100237259A1 (en) * | 2009-03-23 | 2010-09-23 | Chao Wang | Method and device for image guided dynamic radiation treatment of prostate cancer and other pelvic lesions |
Non-Patent Citations (1)
Title |
---|
See also references of EP2736599A4 * |
Also Published As
Publication number | Publication date |
---|---|
CA2843027A1 (en) | 2013-01-31 |
CN103702718A (en) | 2014-04-02 |
EP2736599A1 (en) | 2014-06-04 |
BR112014001790A2 (en) | 2017-06-13 |
RU2014108022A (en) | 2015-10-27 |
EP2736599A4 (en) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI481382B (en) | Assistance device and guiding assembly for percutaneous surgery | |
US9271711B2 (en) | Methods and devices for tissue retraction | |
CN102123677B (en) | Trajectory guide | |
US11452575B2 (en) | Devices and methods to access a target within the body | |
JP7218360B2 (en) | patient-worn surgical support | |
US20090287061A1 (en) | Surgical access device for minimally invasive surgery | |
EP3195833B1 (en) | Surgical instrument | |
AU2015275132B2 (en) | Screw-driven handles and systems for fiducial deployment | |
US9345907B2 (en) | Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield | |
JP2019520915A (en) | Spinal trauma correction and fixation | |
EP1887960B1 (en) | Needle positioning system | |
US10342498B2 (en) | Cannula with image markers to indicate expandable device size | |
US20150223908A1 (en) | System and Method For Simultaneous Deployment of a Plurality of Fiducials | |
US9844683B2 (en) | Device for percutaneous interstitial brachytherapy | |
US9099209B2 (en) | Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield | |
US11191575B2 (en) | Systems and methods for off-axis augmentation of a vertebral body | |
US20130289572A1 (en) | Positional guide | |
EP2736599A1 (en) | Bladder and/or rectum extender with exchangeable and/or slideable tungsten shield | |
US20240138951A1 (en) | Surgical instrument suitable for protecting tissue during bone surgery, for example when cutting or drilling a bone | |
JP2023506435A (en) | Methods and devices for delivering liquid therapeutic agents to solid tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12816877 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2843027 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012816877 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2014108022 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2014108022 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014001790 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112014001790 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140124 |
|
ENP | Entry into the national phase |
Ref document number: 112014001790 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140124 |